Trial NCT01035255

View at ClinicalTrials.gov 
Org. Study IDs: CLCZ696B2314
Secondary IDs: 2009-015834-31

Last trial update was posted on 2016-08-15

MeSH Interventions

Enalapril Sacubitril and valsartan sodium hydrate drug combination

MeSH Conditions

Heart Failure

Other Conditions

Heart Failure With Reduced Ejection Fraction

Stopping Reasons

Early termination was approved due to compelling efficacy of LCZ696 in patients with HF & reduced EF after final pre-specified interim analysis 28-Mar-2014.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID